Wells Fargo’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.29M | Sell |
1,034,644
-153,887
| -13% | -$625K | ﹤0.01% | 2722 |
|
|
2025
Q4 | $7.68M | Buy |
1,188,531
+1,057,145
| +805% | +$6.59M | ﹤0.01% | 2277 |
|
|
2025
Q3 | $734K | Buy |
131,386
+27,955
| +27% | +$121K | ﹤0.01% | 4026 |
|
|
2025
Q2 | $342K | Buy |
103,431
+47,979
| +87% | +$138K | ﹤0.01% | 4409 |
|
|
2025
Q1 | $161K | Buy |
55,452
+3,930
| +8% | +$11.9K | ﹤0.01% | 4836 |
|
|
2024
Q4 | $183K | Buy |
51,522
+18,130
| +54% | +$83.6K | ﹤0.01% | 4846 |
|
|
2024
Q3 | $166K | Buy |
33,392
+1,056
| +3% | +$4.11K | ﹤0.01% | 4700 |
|
|
2024
Q2 | $84.1K | Buy |
32,336
+8,271
| +34% | +$27.6K | ﹤0.01% | 5043 |
|
|
2024
Q1 | $103K | Buy |
24,065
+9,742
| +68% | +$32.4K | ﹤0.01% | 4884 |
|
|
2023
Q4 | $28.9K | Buy |
14,323
+48
| +0.3% | +$85 | ﹤0.01% | 5494 |
|
|
2023
Q3 | $21.8K | Buy |
14,275
+40
| +0.3% | +$69 | ﹤0.01% | 5564 |
|
|
2023
Q2 | $23.5K | Buy |
14,235
+2,854
| +25% | +$5.16K | ﹤0.01% | 5687 |
|
|
2023
Q1 | $13K | Buy |
11,381
+4
| +0% | +$3 | ﹤0.01% | 5769 |
|
|
2022
Q4 | $10.3K | Sell |
11,377
-9,989
| -47% | -$9.38K | ﹤0.01% | 5541 |
|
|
2022
Q3 | $25K | Sell |
21,366
-928
| -4% | -$1.05K | ﹤0.01% | 5284 |
|
|
2022
Q2 | $14K | Buy |
22,294
+194
| +0.9% | +$258 | ﹤0.01% | 5603 |
|
|
2022
Q1 | $58K | Buy |
22,100
+1,100
| +5% | +$3.21K | ﹤0.01% | 5577 |
|
|
2021
Q4 | $82K | Sell |
21,000
-164
| -0.8% | -$823 | ﹤0.01% | 5737 |
|
|
2021
Q3 | $93K | Buy |
21,164
+20
| +0.1% | +$78 | ﹤0.01% | 5414 |
|
|
2021
Q2 | $84K | Sell |
21,144
-120,248
| -85% | -$480K | ﹤0.01% | 5353 |
|
|
2021
Q1 | $735K | Buy |
141,392
+79,751
| +129% | +$424K | ﹤0.01% | 4458 |
|
|
2020
Q4 | $330K | Sell |
61,641
-2,271
| -4% | -$13.6K | ﹤0.01% | 4812 |
|
|
2020
Q3 | $310K | Buy |
63,912
+18,784
| +42% | +$123K | ﹤0.01% | 4689 |
|
|
2020
Q2 | $219K | Buy |
45,128
+36,523
| +424% | +$168K | ﹤0.01% | 4856 |
|
|
2020
Q1 | $19K | Buy |
8,605
+1,605
| +23% | +$6.1K | ﹤0.01% | 5611 |
|
|
2019
Q4 | $41K | Buy |
7,000
+6,000
| +600% | +$31.2K | ﹤0.01% | 5574 |
|
|
2019
Q3 | $3K | Sell |
1,000
-15,646
| -94% | -$58.6K | ﹤0.01% | 6130 |
|
|
2019
Q2 | $70K | Sell |
16,646
-4,722
| -22% | -$24.2K | ﹤0.01% | 5438 |
|
|
2019
Q1 | $148K | Buy |
21,368
+1,595
| +8% | +$11.2K | ﹤0.01% | 4968 |
|
|
2018
Q4 | $124K | Buy |
19,773
+19,034
| +2,576% | +$240K | ﹤0.01% | 5182 |
|
|
2018
Q3 | $13K | Buy |
+739
| New | +$12.2K | ﹤0.01% | 5926 |
|
Other funds holding AQST
BCM
RI
VCM
SB
